Abstract
Purpose
To report a successful case of intractable vernal keratoconjunctivitis treated by papillectomy and amniotic membrane transplantation.
Case summary
A 20-year-old female patient presented with repeated vernal keratoconjunctivitis in both eyes since the age of 14. Despite medical therapy, she developed severe itching, burning and foreign body sensations, and limbal nodules with mu-tiple giant papillae of the upper tarsal plate. Surgical resection of the giant papillae and amniotic membrane transplantation in her left eye was performed. One month later, the same procedure was performed in her right eye. The patient’s symptoms then improved. Neither recurrence nor serious complication were observed during the 6 months follow up period after surgery.
References
2. Heydenreich A, Dietze U. Cryotherapy in vernal conjunctivitis. Klin Monbl Augenheilkd. 1981; 179:116–8.
3. Abiose A, Merz M. Cryosurgery in the management of vernal keratoconjunctivitis. Ann Ophthalmol. 1983; 15:744–7.
4. Tanaka M, Takano Y, Dogru M. . A comparative evaluation of the efficacy of intraoperative mitomycin C use after the excision of cobblestone-like papillae in severe atopic and vernal keratocon- junctivitis. Cornea. 2004; 23:326–9.
5. Nishiwaki-Dantas MC, Dantas PE, Pezzutti S, Finzi S. Surgical re-section of giant papillae and autologous conjunctival graft in patients with severe vernal keratoconjunctivitis and giant papillae. Ophthal Plast Reconstr Surg. 2000; 16:438–42.
6. Tse DT, Mandelbaum S, Epstein E. . Mucous membrane grafting for severe palpebral vernal conjunctivitis. Arch Ophthalmol. 1983; 101:1879–83.
7. Bonnet M, Durand L. Results of treatment of intransigent vernal conjunctivitis by buccal mucosa graft. Bull Mem Soc Fr Ophtalmol. 1968; 81:215–29.
8. Guo P, Kheirkhah A, Zhou WW. . Surgical resection and amni-otic membrane transplantation for treatment of refractory giant papillae in vernal keratoconjunctivitis. Cornea. 2013; 32:816–20.
10. Meller D, Tseng SC. Conjunctival epithelial cell differentiation on amniotic membrane. Invest Ophthalmol Vis Sci. 1999; 40:878–86.
11. Meller D, Pires RT, Tseng SC. Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane cultures. Br J Ophthalmol. 2002; 86:463–71.
12. Hao Y, Ma DH, Hwang DG. . Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. 2000; 19:348–52.
13. Tseng SC, Li DQ, Ma X. Suppression of transforming growth fac-tor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol. 1999; 179:325–35.
14. Li DQ, Lee SB, Tseng SC. Differential expression and regulation of TGF-beta1, TGF-beta2, TGF-beta3, TGF-betaRI, TGF-betaRII and TGF-betaRIII in cultured human corneal, limbal, and con-junctival fibroblasts. Curr Eye Res. 1999; 19:154–61.
15. Tseng SC, Prabhasawat P, Lee SH. Amniotic membrane trans-plantation for conjunctival surface reconstruction. Am J Ophthalmol. 1997; 124:765–74.
16. Tseng SC, Prabhasawat P, Barton K. . Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol. 1998; 116:431–41.
17. Kheirkhah A, Casas V, Esquenazi S. . New surgical approach for superior conjunctivochalasis. Cornea. 2007; 26:685–91.
18. Singh S, Pal V, Dhull CS. Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis. Indian J Ophthalmol. 2001; 49:241–5.